Nori Human AIF1 ELISA Kit

Price range: $508.00 through $916.00

This ELISA kit is for quantification of AIF1 in human. This is a quick ELISA assay that reduces time to 50% compared to the conventional method, and the entire assay only takes 3 hours. This assay employs the quantitative sandwich enzyme immunoassay technique and uses biotin-streptavidin chemistry to improve the performance of the assays. An antibody specific for AIF1 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and any AIF1 present is bound by the immobilized antibody. After washing away any unbound substances, a detection antibody specific for AIF1 is added to the wells. Following wash to remove any unbound antibody reagent, a detection reagent is added. After intensive wash a substrate solution is added to the wells and color develops in proportion to the amount of AIF1 bound in the initial step. The color development is stopped, and the intensity of the color is measured.

Alternative names for AIF1: Allograft inflammatory factor 1 (AIF-1), ionized calcium-binding adapter molecule 1 (IBA1)

 

This product is for laboratory research use only not for diagnostic and therapeutic purposes or any other purposes.

CAT: GR111315 Categories: , Tag:

Description

Nori Human AIF1 ELISA Kit Summary

Alternative names for AIF1: Allograft inflammatory factor 1 (AIF-1), ionized calcium-binding adapter molecule 1 (IBA1)

Assay Type Solid Phase Sandwich ELISA
Format 96-well Microplate or 96-Well Strip Microplate
Method of Detection Colorimetric
Number of Targets Detected 1
Target Antigen Accession Number P55008
Assay Length 3 hours
Quantitative/Semiquantitative Quantitative
Sample Type Plasma, Serum, Cell Culture, Urine, Cell/Tissue Lysates, Synovial Fluid, BAL,
Recommended Sample Dilution (Plasma/Serum) No dilution for sample <ULOQ; sufficient dilution for samples >ULOQ
Sensitivity 6 pg/mL
Detection Range 31.25-2000 pg/mL
Specificity Human AIF1
Cross-Reactivity < 0.5% cross-reactivity observed with available related molecules, < 50% cross-species reactivity observed with species tested.
Interference No significant interference observed with available related molecules
Storage/Stability 4 ºC for up to 6 months
Usage For Laboratory Research Use Only. Not for diagnostic or therapeutic use.
Additional Notes The kit allows for use in multiple experiments.

 

Standard Curve

Kit Components
1. Pre-coated 96-well Microplate
2. Biotinylated Detection Antibody
3. Streptavidin-HRP Conjugate
4. Lyophilized Standards
5. TMB One-Step Substrate
6. Stop Solution
7. 20 x PBS
8. Assay Buffer

Other Materials Required but not Provided:
1. Microplate Reader capable of measuring absorption at 450 nm
2. Log-log graph paper or computer and software for ELISA data analysis
3. Precision pipettes (1-1000 µl)
4. Multi-channel pipettes (300 µl)
5. Distilled or deionized water

Protocol Outline
1. Prepare all reagents, samples and standards as instructed in the datasheet.
2. Add 100 µl of Standard or samples to each well and incubate 1 h at RT.
3. Add 100 µl of Working Detection Antibody to each well and incubate 1 h at RT.
4. Add 100 µl of Working Streptavidin-HRP to each well and incubate 20 min at RT.
5. Add 100 µl of Substrate to each well and incubate 5-30 min at RT.
6. Add 50 µl of Stop Solution to each well and read at 450 nm immediately.

Background: 

Allograft inflammatory factor 1 (AIF-1) also known as ionized calcium-binding adapter molecule 1 (IBA1) is a protein that is encoded by the AIF1 gene.[1] AIF1 exists in the cytoplasm and is highly evolutionarily conserved. It is also possibly identical to three other proteins, Iba-2, MRF-1 and daintain. However complete functional profiles of all three proteins and how they overlap is unknown.[2] IBA1 is a 17-kDa EF hand protein that is specifically expressed in macrophages/microglia and is upregulated during the activation of these cells. Iba1 expression is up-regulated in microglia following nerve injury,[3] central nervous system ischemia, and several other brain diseases. AIF1 was originally discovered in atherosclerotic lesions in a rat model of chronic allograft cardiac rejection. It was upregulated in macrophages and neutrophils in response to IFN-γ.[4] AIF1 expression has increased in vascular tissue in response to arterial injury, specifically in activated vascular smooth muscle cells in response to IFN-γ, IL-1β, and T-cell conditioned media.[5] AIF1 enhances growth and promotes proliferation in vascular smooth muscle cells through deregulation of the cell cycle by shortening the cell cycle and altering the expression of cyclins.[6] Though histologically different, AIF1 promotes the proliferation and activation of endothelial cells (EC).[7]  AIF1 been shown to interact with kinase p44/42 and PAK1, two previously known signal transduction molecules, in regulating these processes. Allograft Inflammatory Factor 1 is found in activated macrophages that are found in tissues with inflammation. AIF1 levels in healthy humans have been found to positively correlate with metabolic indicators, such as body mass index, triglycerides, and fasting plasma glucose levels. The excess of adipose tissue found in obese patients is found to cause chronic inflammation with an increase in the number of activated macrophages. Subsequently, AIF1 may be an accurate indicator of macrophage activation in the body.[8] There is also evidence that AIF1 could be a marker for diabetic nephropathy when detected in serum.[9] It is found in activated macrophages in the pancreatic islets, and has been shown to decrease insulin secretion, while simultaneously impairing glucose elimination.[10]

References

  1. Autieri MV (1996). Biochem Biophys Res Commun. 228 (1): 29–37.
  2. Deininger MH, et al. (2002). FEBS Lett. 514 (2–3): 115–21.
  3. Ito D, Imai Y, et al. (1998). Brain Res. Mol. Brain Res. 57 (1): 1–9.
  4. Utans U, et al. (1995). J. Clin. Invest. 95 (6): 2954–62.
  5. Autieri MV, et al. (2000). Arterioscler. Thromb. Vasc. Biol. 20 (7): 1737–44.
  6. Autieri MV, Carbone CM (2001). Arterioscler. Thromb. Vasc. Biol. 21 (9): 1421–6.
  7. Tian Y, et al. (2009). Am. J. Physiol., Cell Physiol. 296 (2): C256–66.
  8. Fukui M, et al. (2012). Metab. Clin. Exp. 61 (7): 1021–5.
  9. Fukui M, et al. (2012). Diabetes Res. Clin. Pract. 97 (1): 146–50.
  10. Chen ZW, et al. (1997). Proc. Natl. Acad. Sci. U.S.A. 94 (25): 13879–84.

DATASHEET

MSDS: Available upon request.

CoA: Available upon request.

Product Citations

Reviews

There are no reviews yet.


Be the first to review “Nori Human AIF1 ELISA Kit”